Kepler Capital analyst Mats Liss maintained a Buy rating on Fagerhult AB (2F0 – Research Report) on January 23 and set a price target of ...
Retina specialists have a lot of options when it comes to intravitreal injection procedures, according to a speaker at Retina ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback